News
PMD
--
0.00%
--
Trade Alert: Peter Kamin At Psychemedics Corporation (NASDAQ:PMD), Has Just Spent US$258k Buying 44% More Shares
Potential Psychemedics Corporation ( NASDAQ:PMD ) shareholders may wish to note that insider Peter Kamin recently...
Simply Wall St. · 01/02 07:47
Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel
Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel.
GlobeNewswire · 12/17/2020 15:31
Sarah Ashby Rejoins Psychemedics Corporation as Vice President, General Counsel
ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel. In this important role, Sarah will be responsible for directing and managing all...
GlobeNewswire · 12/17/2020 15:31
Where Do Hedge Funds Stand On Psychemedics Corp. (PMD)?
In this article you are going to find out whether hedge funds think Psychemedics Corp. (NASDAQ:PMD) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have bee...
Insider Monkey · 11/29/2020 19:22
Where Do Hedge Funds Stand On Psychemedics Corp. (PMD)?
In this article you are going to find out whether hedge funds think Psychemedics Corp. (NASDAQ:PMD) is a good investment right now. We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among […]
Insider Monkey · 11/29/2020 19:22
Psychemedics Announces Third Quarter Results
Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020.
GlobeNewswire · 11/09/2020 22:29
Psychemedics Announces Third Quarter Results
Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020.
GlobeNewswire · 11/09/2020 22:29
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 29)
Benzinga · 10/30/2020 12:09
The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 28)
Benzinga · 10/29/2020 11:30
The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 26)
Benzinga · 10/27/2020 12:24
The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14)
Benzinga · 10/15/2020 12:03
The Daily Biotech Pulse: Patent Award For Theratechnologies, Enzo Biochem's Q4, Codiak Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 13)
Benzinga · 10/14/2020 11:53
The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12)
Benzinga · 10/13/2020 12:20
Industry News: At-Home Drug of Abuse (DOA) Testing Market share will grow at CAGR of 8.7 % says Marketstudyreport
Selbyville, Delaware. The report At-Home Drug of Abuse (DOA) Testing Market Analysis and forecast 2023 maintains enhanced dynamics and is overshadowed by a top player across the globe. The research report provides At-Home Drug of Abuse (DOA) Testing Market analysis and information corresponding to market segments such as geographies, product type, application, and end-use industry. Experts use the most recent At-Home Drug of Abuse (DOA) Testing Market research techniques and tools to assemble widespread and precise marketing research reports. A detailed outline about At-Home Drug of Abuse (DOA) Testing market size and share were combined in this report which gives a comprehensive analysis of different verticals of businesses.
Market Insight Reports · 10/12/2020 18:05
Industry News: At-Home Drug of Abuse (DOA) Testing Market share will grow at CAGR of 8.7 % says Marketstudyreport
Selbyville, Delaware. The report At-Home Drug of Abuse (DOA) Testing Market Analysis and forecast 2023 maintains enhanced dynamics and is overshadowed by a top player across the globe. The research report provides At-Home Drug of Abuse (DOA) Testing Market...
Market Insight Reports · 10/12/2020 18:05
Praxis Precision Medicines Readies $126 Million IPO
Praxis Precision Medicines has filed proposed terms for its U.S. IPO.The firm is developing treatments for various central nervous system and other disorders.PRAX has demonstrated positive early efficacy results, so for life science investors, the IPO is worth a close look.
Seekingalpha · 10/11/2020 15:35
The Daily Biotech Pulse: Gilead, Lilly COVID-19 Treatment Supply Agreements, CareDx's Positive Preannouncement, Aziyo Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-Week Highs Oct. 7)
Benzinga · 10/08/2020 11:52
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 24)
Benzinga · 09/25/2020 11:37
Global At-Home Drug of Abuse (DOA) Testing Market 2020 Growth Factors, Product Overview, Segmentation and Forecast Study to 2025
A new report by titled, has been released with trustworthy information and detailed forecasts for a better understanding of the present market scenario. The report presents the complete business and technical outlook of the global At-Home Drug of Abuse (...
CDN Newswire · 09/23/2020 18:27
Global At-Home Drug of Abuse (DOA) Testing Market 2020 Growth Factors, Product Overview, Segmentation and Forecast Study to 2025
A new report by titled, has been released with trustworthy information and detailed forecasts for a better understanding of the present market scenario. The report presents the complete business and technical outlook of the global At-Home Drug of Abuse (DOA) Testing market. The report offers an in-depth analysis of the global market, including qualitative insights, historical data, and verifiable projections about the market size and share. The research evaluates the growth rate and revenue, in terms of demand and supply, cost structure, barriers and challenges, product type, key market players, technology, regions, and applications.
CDN Newswire · 09/23/2020 18:27
Webull provides a variety of real-time PMD stock news. You can receive the latest news about Psychemedics through multiple platforms. This information may help you make smarter investment decisions.
About PMD
Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment. The Company is in the business of performing drug testing and reporting the results thereof. The Company's drug testing services include training for collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit tested of samples. The Company's primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. The Company's tests provide information that indicates the approximate amount of drug ingested, as well as historical data, which shows a pattern of individual drug use over a longer period of time.
More